Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokines

Cancer Science

Volumn 101, Issue 2, 2010, Pages 536-542

  Satsuka, Ayano ^a,b   Yoshida, Satoshi ^a,c   Kajitani, Naoko ^a,b   Nakamura, Hiroyasu ^a,c   Sakai, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Graduate School of Bioscience   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; REPLICON; SKIN FIBROBLAST; VIROGENESIS; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOKINES; DNA, VIRAL; HUMAN PAPILLOMAVIRUS 18; HUMANS; REPLICON; VIRUS REPLICATION;

EID: 75649142951     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01411.x     Document Type: Article

References (41)

1. Howley PM, Lowy DR, Knipe DM, Howley PM. Papillomavirus and their replication. Fields Virology 2007, 2299-354. In, eds, 5th edn, Hagerstown, Lippincott Williams & Wilkins,a Wolters Kluwer Business
2. Durst M, Gissmann L, Ikenberg H, Zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983, 80:3812-5.
3. Zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:F55-78.
4. Castellsagué X, De Sanjosé S, Aguado T. HPV and cervical cancer in the 2007 report. Vaccine 2007, 25(Suppl 3):C1-230.
5. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004, 68:362-72.
6. Flores ER, Lambert PF. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol 1997, 71:7167-79.
7. Adams JC, Watt FM. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989, 340:307-9.
8. Ruesch MN, Laimins LA. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virol 1998, 250:19-29.
9. Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992, 257:971-3.
10. Dollard SC, Wilson JL, Demeter LM. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF Genes Dev 1992, 6:1131-42.
11. Frattini MG, Lim HB, Laimins LA. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc Natl Acad Sci U S A 1996, 93:3062-7.
12. Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A 2007, 104:19541-6.
13. Frattini MG, Lim HB, Doorbar J, Laimins LA. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J Virol 1997, 71:7068-72.
14. Strauss WM, Ausubel FM, Brent R, Kingston RE. Preparation of genomic DNA from mammalian tissue. Current Protocols in Molecular Biology 1998, 2.1-2.3.. In, eds, New York, John Wiley & Sons, Inc
15. Yoshida S, Kajitani N, Satsuka A, Nakamura H, Sakai H. Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins. J Virol 2008, 82:8820-7.
16. Ueno T, Sasaki K, Yoshida S. Molecular mechanisms of hyperplasia induction by human papillomavirus E7. Oncogene 2006, 25:4155-64.
17. Tsunenaga M, Kohno Y, Horii I. Growth and differentiation properties of normal and transformed human keratinocytes in organotypic culture. Jpn J Cancer Res 1994, 85:238-44.
18. Sambrool J, Fritsch EF, Maniatis T. Molecular Cloning 1989, 18.30-3. New York, Cold Spring Harbor Laboratory Press
19. Wang HK, Duffy AA, Broker TR, Chow LT. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 2009, 23:181-94.
20. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 2000, 114:444-55.
21. Flores ER, Allen-Hoffmann BL, Lee D, Sattler CA, Lambert PF. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virol 1999, 262:344-54.
22. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 2000, 74:6622-31.
23. Frazer IH, McMillan NAJ, Penny S-HaRW. Papillomatosis and condylomata acuminata. Clinical Applications of the Interferons 1997, 79-91. In, ed, London, Chapman and Hall Medical
24. Donalisio M, Cornaglia M, Landolfo S, Lembo D. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells. Virus Res 2008, 132:253-6.
25. Nindl I, Steenbergen RD, Schurek JO, Meijer CJ, Van der Valk P, Snijders PJ. Assessment of TGF-beta1-mediated growth inhibition of HPV-16- and HPV-18-transfected foreskin keratinocytes during and following immortalization. Arch Dermatol Res 2003, 295:297-304.
26. Villa LL, Vieira KB, Pei XF, Schlegel R. Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18. Mol Carcinog 1992, 6:5-9.
27. Vieira KB, Goldstein DJ, Villa LL. Tumor necrosis factor alpha interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes. Cancer Res 1996, 56:2452-7.
28. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci U S A 1995, 92:2840-4.
29. Kyo S, Inoue M, Hayasaka N. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virol 1994, 200:130-9.
30. Zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 1999, 9:405-11.
31. Dong W, Kloz U, Accardi R. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 2005, 79:14899-908.
32. Galloway DA. Human papillomaviruses: a growing field. Genes Dev 2009, 23:138-42.
33. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002, 89:213-28.
34. Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007, 220:214-24.
35. Stanley MA, Pett MR, Coleman N. HPV: from infection to cancer. Biochem Soc Trans 2007, 35:1456-60.
36. Koromilas AE, Li S, Matlashewski G. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev 2001, 12:157-70.
37. Terenzi F, Saikia P, Sen GC. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J 2008, 27:3311-21.
38. Li S, Labrecque S, Gauzzi MC. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 1999, 18:5727-37.
39. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998, 12:2061-72.
40. Perea SE, Massimi P, Banks L. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int J Mol Med 2000, 5:661-6.
41. Antonsson A, Payne E, Hengst K, McMillan NA. The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation. J Interferon Cytokine Res 2006, 26:455-61.